IMVT
Immunovant, Inc. · Healthcare
Roivant Sciences Ltd. bought $336.9M of Immunovant, Inc.
Director and 10% owner
Bought$336,900,200
$20.00Price
16,845,010Shares
+21%Stake
What IMVT did for a copier
- $1,000 copied at Thu, Jan 16 open, $24.88
- $741
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Mar 3 close.
Roivant Sciences Ltd.'s record
14 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Jan 13. Filed Wed, Jan 15, 4:36 PM ET, after the close. Returns use the Jan 16 open and the Mar 3 close. Not investment advice.